REQUEST A DEMO
Total
USD $0.00
Search more companies

Medis Pharma Lithuania UAB (Lithuania)

Main Activities: Administrative Management and General Management Consulting Services
Full name: Medis Pharma Lithuania UAB Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Medis Pharma Lithuania UAB is an enterprise based in Lithuania. Its main office is in Kaunas. It operates in the Administrative Management and General Management Consulting Services sector. It was first established on December 23, 2019. 7 (2025) employees currently work for Medis Pharma Lithuania UAB. There was a net sales revenue increase of 42.16% reported in Medis Pharma Lithuania UAB’s latest financial highlights for 2025. The enterprise’s net profit margin increased by 0.77% in 2025.

Headquarters
Kursiu g. 7-23
Kaunas; Kaunas County; Postal Code: LT-48107

Contact Details: Purchase the Medis Pharma Lithuania UAB report to view the information.

Basic Information
Total Employees:
Purchase the Medis Pharma Lithuania UAB report to view the information.
Registered Capital:
Purchase the Medis Pharma Lithuania UAB report to view the information.
Financial Auditors:
Purchase the Medis Pharma Lithuania UAB report to view the information.
Incorporation Date:
December 23, 2019
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Medis Pharma Lithuania UAB report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
42.16%▲
Total Operating Revenue
42.16%▲
Net Profit/Loss for the Period
92.09%▲
Total Equity
57.81%▲
Net Profit Margin
0.77%▲
Return on Equity (ROE)
6.54%▲

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?